Author: Ken Dropiewski

BioSig PURE EP System Featured in the Editorial of EP Lab Digest

Westport, CT, Jan. 14, 2021 (GLOBE NEWSWIRE) — Leading industry publication calls attention to ongoing challenges in the electrophysiology lab PURE EP System is highlighted as a novel technological solution BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed […]

HCPLive® Adds The American Society for Preventive Cardiology to Its Strategic Alliance Partnership Program

CRANBURY, N.J.–(BUSINESS WIRE)–HCPLive® and The American Journal of Managed Care® (AJMC®) are excited to announce the addition of The American Society for Preventive Cardiology (ASPC) to their Strategic Alliance Partnership (SAP) programs. “We’re very honored to be able to join forces with ASPC to help promote the prevention of cardiovascular disease,” said Mike Hennessy Jr., […]

Elixir Medical Announces First Patient Treated in BIOADAPTOR Randomized Controlled Trial of DynamX Coronary Bioadaptor System

International Trial to Compare Bioadaptor, a Novel Coronary Artery Implant Designed to Adapt to Vessel Physiology, with Traditional Drug Eluting Stents MILPITAS, Calif.–(BUSINESS WIRE)–Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, today announced that the first patient has been treated in the BIOADAPTOR randomized controlled trial (RCT) of the DynamX™ […]

ESPERION Reports Preliminary Fourth Quarter 2020 Financial Results and Further Commits to Unmet Patient Needs with Oral PCSK9 Inhibitor Program

– Fourth-quarter 2020 U.S. net product revenue estimated between $8.0 and $8.5 million – – Range represents over 140 percent sequential growth for NEXLETOL® (bempedoic acid) tablets and NEXLIZET® (bempedoic acid and ezetimibe) tablets – – Company provides full-year 2021 operating expense guidance – – In-licensed oral PCSK9 inhibitor program furthers ESPERION […]

Acutus Medical Reports Preliminary, Unaudited Fourth Quarter and Full Year 2020 Results

CARLSBAD, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported preliminary unaudited revenue results for the quarter and full year ended December 31, 2020. Preliminary Fourth Quarter and Full […]

Cytokinetics Announces First Patient Dosed in Cohort 2 of Redwood-HCM

Company Earns $2.5 Million Milestone Payment from Ji Xing Pharmaceuticals SOUTH SAN FRANCISCO, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Inc. (Nasdaq: CYTK) today announced that the first patient has been dosed in Cohort 2 of REDWOOD-HCM (Randomized Evaluation of Dosing With CK-274 in Obstructive Outflow Disease in HCM), an ongoing Phase 2 clinical trial of […]

Positive preliminary data from Acarix’s exploratory heart failure study SEISMO

Press release Malmö, Sweden, January 13, 2021 Positive preliminary data from Acarix’s exploratory heart failure study SEISMO Acarix AB (publ) today announced positive preliminary data from the exploratory SEISMO study, using its modified CADScor®System on a potential heart failure application. The SEISMO trial was initiated in June 2018 to evaluate […]

Mentice to enhance its organization with several new key positions

STOCKHOLM, Jan. 13, 2021 /PRNewswire/ — Mentice AB (publ), a leading supplier of high-tech solutions for simulation in the medical sector, with focus on endovascular procedures, has announced changes to its organization. Several new key positions have been created, aimed at improving Mentice’s regional presence in the market. Effective January 1st, Mentice has adopted a […]

VivaLNK Provides Cardiac Patch for Sleep Bruxism Study

Wearable ECG monitor used in study on Emotion Dysregulation and Sleep Time Masticatory Muscle Activity CAMPBELL, Calif., Jan. 13, 2021 /PRNewswire/ — VivaLNK, a leading provider of connected healthcare solutions, announces an agreement to supply its wearable ECG monitors to Stanford University for research on sleep bruxism. Titled “Emotion Dysregulation and Sleep-Time Masticatory Muscle Activity […]

Inari Medical Reports Preliminary Fourth Quarter 2020 Revenue

IRVINE, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — Inari Medical Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today reported preliminary unaudited fourth quarter 2020 revenue. Preliminary Fourth Quarter Revenue and Business Highlights: Preliminary unaudited […]